© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Universe Pharmaceuticals Inc. (UPC) stock declined over -6.77%, trading at $4.27 on NASDAQ, down from the previous close of $4.58. The stock opened at $4.31, fluctuating between $4.27 and $4.59 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 01, 2026 | 4.61 | 4.75 | 4.26 | 4.27 | 9K |
| Aug 31, 2026 | 4.78 | 5.01 | 4.58 | 4.58 | 13.34K |
| Aug 28, 2026 | 4.95 | 5.55 | 4.58 | 4.90 | 18.01K |
| Aug 27, 2026 | 5.21 | 5.50 | 4.60 | 5.04 | 51.74K |
| Aug 26, 2026 | 5.03 | 5.91 | 5.03 | 5.32 | 96.75K |
| Aug 25, 2026 | 5.16 | 5.36 | 5.03 | 5.03 | 12.76K |
| Aug 24, 2026 | 5.29 | 5.36 | 5.11 | 5.36 | 19.46K |
| Aug 21, 2026 | 5.18 | 5.36 | 5.11 | 5.30 | 5.25K |
| Aug 20, 2026 | 5.26 | 5.45 | 5.03 | 5.33 | 17.39K |
| Aug 19, 2026 | 5.12 | 5.60 | 5.12 | 5.34 | 9.59K |
| Aug 18, 2026 | 5.56 | 5.61 | 5.21 | 5.23 | 29.07K |
| Aug 17, 2026 | 5.60 | 5.84 | 5.53 | 5.78 | 23.92K |
| Aug 14, 2026 | 5.92 | 6.10 | 5.57 | 5.65 | 32.36K |
| Aug 13, 2026 | 6.01 | 6.21 | 5.67 | 5.87 | 19.21K |
| Aug 12, 2026 | 6.08 | 6.08 | 5.57 | 6.06 | 24.98K |
| Aug 11, 2026 | 7.00 | 7.00 | 5.69 | 5.94 | 67.45K |
| Aug 10, 2026 | 5.50 | 7.50 | 5.50 | 7.09 | 291.97K |
| Aug 07, 2026 | 6.38 | 6.38 | 5.51 | 5.56 | 69.72K |
| Aug 06, 2026 | 5.67 | 6.24 | 5.52 | 6.24 | 88.85K |
| Aug 05, 2026 | 7.11 | 7.33 | 6.00 | 6.16 | 276.17K |
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
| Employees | 216 |
| Beta | 1.53 |
| Sales or Revenue | $32.31M |
| 5Y Sales Change% | 5.564% |
| Fiscal Year Ends | September |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |